MRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticles

In recent years, there has been increasing interest in developing a multifunctional nanoscale platform for cancer monitoring and chemotherapy. However, there is still a big challenge for current clinic contrast agents to improve their poor tumor selectivity and response. Herein, we report a new kind...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bo, Lu, Shu-Ting, Deng, Kai, Yu, Hui, Cui, Can, Zhang, Yang, Wu, Ming, Zhuo, Ren-Xi, Xu, Hai-Bo, Huang, Shi-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604569/
https://www.ncbi.nlm.nih.gov/pubmed/29066883
http://dx.doi.org/10.2147/IJN.S143048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604569/
https://www.ncbi.nlm.nih.gov/pubmed/29066883
http://dx.doi.org/10.2147/IJN.S143048

Ejemplares similares